| 1 |
33531766 | Cost-Effectiveness of Emergent MRI during Stroke Alert to Diagnose Stroke Mimics: Single-Center Experience. | 2021 Jan |
1 |
| 2 |
34274479 | Mitogen-induced transcriptional programming in human fibroblasts. | 2021 Oct 20 |
1 |
| 3 |
31490714 | The Association between Presentation by EMS and EMS Prenotification with Receipt of Intravenous Tissue-Type Plasminogen Activator in a State Implementing Stroke Systems of Care. | 2020 May-Jun |
1 |
| 4 |
32132496 | Thrombolysis for Acute Ischemic Stroke Following Transcatheter Aortic Valve Replacement: Case Report and Literature Review. | 2020 Mar |
1 |
| 5 |
30642680 | Cost-effectiveness analysis of mechanical thrombectomy plus tissue-type plasminogen activator compared with tissue-type plasminogen activator alone for acute ischemic stroke in France. | 2019 Apr |
1 |
| 6 |
31271729 | Differential expression of the TPα and TPβ isoforms of the human T Prostanoid receptor during chronic inflammation of the prostate: Role for FOXP1 in the transcriptional regulation of TPβ during monocyte-macrophage differentiation. | 2019 Oct |
4 |
| 7 |
31334875 | Elevation of high-sensitivity cardiac troponin T at admission is associated with increased 3-month mortality in acute ischemic stroke patients treated with thrombolysis. | 2019 Oct |
1 |
| 8 |
29422380 | Improvement in Door-to-Needle Time in Patients with Acute Ischemic Stroke via a Simple Stroke Activation Protocol. | 2018 Jun |
1 |
| 9 |
29859810 | uPA/uPAR signaling in rheumatoid arthritis: Shedding light on its mechanism of action. | 2018 Aug |
1 |
| 10 |
26991747 | Ischemic stroke subtype is associated with outcome in thrombolyzed patients. | 2017 Feb |
1 |
| 11 |
28028150 | Cost-Effectiveness of Solitaire Stent Retriever Thrombectomy for Acute Ischemic Stroke: Results From the SWIFT-PRIME Trial (Solitaire With the Intention for Thrombectomy as Primary Endovascular Treatment for Acute Ischemic Stroke). | 2017 Feb |
1 |
| 12 |
28060219 | Multicenter Study of Adverse Events After Intravenous Tissue-Type Plasminogen Activator Treatment of Acute Ischemic Stroke. | 2017 Feb |
1 |
| 13 |
28840015 | A review of the management of complex para-pneumonic effusion in adults. | 2017 Jul |
1 |
| 14 |
25516146 | Is the Susceptibility Vessel Sign on 3-Tesla Magnetic Resonance T2*-Weighted Imaging a Useful Tool to Predict Recanalization in Intravenous Tissue Plasminogen Activator? | 2016 Sep |
1 |
| 15 |
27266620 | Patients with Low National Institutes of Health Stroke Scale Scores Have Longer Door-to-Needle Times: Analysis of a Telestroke Network. | 2016 Sep |
1 |
| 16 |
25845759 | Safety of intravenous thrombolysis for acute ischemic stroke in specific conditions. | 2015 Jun |
1 |
| 17 |
26288668 | Intravenous Thrombolysis for Acute Ischemic Stroke Within 3 Hours Versus Between 3 and 4.5 Hours of Symptom Onset. | 2015 Jul |
1 |
| 18 |
24335814 | Intravenous tissue-type plasminogen activator therapy is an independent risk factor for symptomatic intracerebral hemorrhage after carotid endarterectomy. | 2014 Mar |
1 |
| 19 |
25307224 | Combination approaches to attenuate hemorrhagic transformation after tPA thrombolytic therapy in patients with poststroke hyperglycemia/diabetes. | 2014 |
1 |
| 20 |
25352486 | Simple text-messaging intervention is associated with improved door-to-needle times for acute ischemic stroke. | 2014 Dec |
1 |
| 21 |
23704110 | Systemic inflammatory response syndrome in tissue-type plasminogen activator-treated patients is associated with worse short-term functional outcome. | 2013 Aug |
1 |
| 22 |
21415399 | Pretreatment diffusion-weighted imaging lesion volume predicts favorable outcome after intravenous thrombolysis with tissue-type plasminogen activator in acute ischemic stroke. | 2011 May |
1 |
| 23 |
21527758 | A new therapeutic strategy for acute ischemic stroke: sequential combined intravenous tPA-tenecteplase for proximal middle cerebral artery occlusion based on first results in 13 consecutive patients. | 2011 Jun |
1 |
| 24 |
21980194 | Intracranial hemorrhage, outcome, and mortality after intra-arterial therapy for acute ischemic stroke in patients under oral anticoagulants. | 2011 Nov |
1 |
| 25 |
20539748 | Translational stroke research using a rabbit embolic stroke model: a correlative analysis hypothesis for novel therapy development. | 2010 Jun |
1 |
| 26 |
25214955 | Efficacy of a new mutated recombinant tissue-type plasminogen activator in beagles with acute coronary artery thrombi. | 2010 |
1 |
| 27 |
19747485 | Regulated expression of the alpha isoform of the human thromboxane A2 receptor during megakaryocyte differentiation: a coordinated role for WT1, Egr1, and Sp1. | 2009 Nov 20 |
2 |
| 28 |
18647223 | Retinoids and activation of PKC induce tissue-type plasminogen activator expression and storage in human astrocytes. | 2008 Oct |
3 |
| 29 |
16733850 | Identification of biomarkers of human pancreatic adenocarcinomas by expression profiling and validation with gene expression analysis in endoscopic ultrasound-guided fine needle aspiration samples. | 2006 Jun 7 |
1 |
| 30 |
15583828 | Expression of matrix metalloproteinase 9 and its regulators in the unstable coronary atherosclerotic plaque. | 2005 Jan |
1 |
| 31 |
15709120 | Arterial occlusion revealed by CT angiography predicts NIH stroke score and acute outcomes after IV tPA treatment. | 2005 Feb |
1 |
| 32 |
16148738 | IV tPA for acute ischemic stroke: results of the first 101 patients in a community practice. | 2005 Sep |
1 |
| 33 |
15081395 | Expression and regulation of phospholipase D isoforms in sphingosine and phorbol ester-stimulated glioma C6 cells. | 2004 May 7 |
1 |
| 34 |
12665395 | Clinical potential of intra-arterial thrombolytic therapy in patients with acute ischaemic stroke. | 2003 |
1 |
| 35 |
12729646 | New fibrinolytic agents: benzothiophene derivatives as inhibitors of the t-PA-PAI-1 complex formation. | 2003 May 19 |
1 |
| 36 |
12928328 | Interaction of the actin cytoskeleton with microtubules regulates secretory organelle movement near the plasma membrane in human endothelial cells. | 2003 Oct 1 |
1 |
| 37 |
11815600 | Phorbol ester activation of a proteolytic cascade capable of activating latent transforming growth factor-betaL a process initiated by the exocytosis of cathepsin B. | 2002 Apr 26 |
1 |
| 38 |
12161520 | Nuclear factor-kappa B is required for tumor necrosis factor-alpha-induced manganese superoxide dismutase expression in human endometrial stromal cells. | 2002 Aug |
1 |
| 39 |
11179965 | Ectopic expression of the cAMP-responsive element binding protein inhibits phorbol ester-mediated induction of tissue-type plasminogen activator gene expression. | 2001 Feb |
1 |
| 40 |
11434688 | Adenovirus-mediated expression and packaging of tissue-type plasminogen activator in megakaryocytic cells. | 2001 Jun |
4 |
| 41 |
11558838 | Issues in the assessment of the safety and efficacy of tenecteplase (TNK-tPA). | 2001 Sep |
1 |
| 42 |
11668484 | Interferon-gamma cooperates with retinoic acid and phorbol ester to induce differentiation and growth inhibition of human neuroblastoma cells. | 2001 Oct 1 |
1 |
| 43 |
10703777 | Use of tissue-type plasminogen activator for acute ischemic stroke: the Cleveland area experience. | 2000 Mar 1 |
1 |
| 44 |
11018526 | Overexpression of a dominant negative CREB protein in HT-1080 cells selectively disrupts plasminogen activator inhibitor type 2 but not tissue-type plasminogen activator gene expression. | 2000 Sep 29 |
2 |
| 45 |
11029286 | Effect of HCO(3)(-) on TPA- and IBMX-induced anion conductances in Necturus gallbladder epithelial cells. | 2000 Nov |
1 |
| 46 |
11741223 | Synthesis and characterization of positively charged tPA as a prodrug using heparin/protamine-based drug delivery system. | 2000 |
1 |
| 47 |
10543954 | The variable region-1 from tissue-type plasminogen activator confers specificity for plasminogen activator inhibitor-1 to thrombin by facilitating catalysis: release of a kinetic block by a heterologous protein surface loop. | 1999 Oct 29 |
1 |
| 48 |
9851700 | Transcriptional regulation of the tissue-type plasminogen-activator gene in human endothelial cells: identification of nuclear factors that recognise functional elements in the tissue-type plasminogen-activator gene promoter. | 1998 Nov 15 |
4 |
| 49 |
9016559 | Cell-type specific DNA-protein interactions at the tissue-type plasminogen activator promoter in human endothelial and HeLa cells in vivo and in vitro. | 1997 Jan 15 |
4 |
| 50 |
9241751 | Effects of heparin therapy on fibrinolysis in patients with pulmonary embolism. | 1997 Jun |
1 |